Determination and characterization of degradation products of Anastrozole by LC-MS/MS and NMR spectroscopy

Journal of Pharmaceutical and Biomedical Analysis

Volumn 56, Issue 5, 2011, Pages 962-968

  Sitaram, Cheekatla ^a,b   Rupakula, Ravichandrababu ^b   Reddy, B N ^a  

^a Ogene Systems (I) Pvt Ltd   (India)

^b GITAM UNIVERSITY   (India)

Author keywords

Anastrozole; Development; Forced degradation; Stability indicating method; Validation

Indexed keywords

ACETONITRILE; AMMONIUM FORMATE; ANASTROZOLE; CARBROMAL; MONOACID; UNCLASSIFIED DRUG;

ALKALINITY; ARTICLE; DRUG DEGRADATION; DRUG DETERMINATION; DRUG IMPURITY; DRUG PURITY; DRUG STABILITY; ELUTION; LIQUID CHROMATOGRAPHY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OXIDATION; PHOTOLYSIS; PRIORITY JOURNAL; TANDEM MASS SPECTROMETRY;

AROMATASE INHIBITORS; CHROMATOGRAPHY, LIQUID; MAGNETIC RESONANCE SPECTROSCOPY; NITRILES; REPRODUCIBILITY OF RESULTS; TANDEM MASS SPECTROMETRY; TRIAZOLES;

EID: 80052816699     PISSN: 07317085     EISSN: 1873264X     Source Type: Journal    
DOI: 10.1016/j.jpba.2011.08.022     Document Type: Article

References (15)

1. International Conference on Harmonization Guideline for Impurities in New Drug Substances; Q3A (R2) 2006.
2. The Merck Index 2006, vol. 14. Merck & Co., Inc., Whitehouse Station, NJ, USA, p. 622.
3. Saravanan G., Suryanarayana M.V., Jadhav M.J., Ravikumar M., Someswara Rao N., Acharyulu P.V.R. A stress stability behavior and development of an LC assay method for anastrozole. Chromatographia 2007, 66:435-438.
4. Hiriyanna S.G., Basavaiah K. Isolation and characterization of process related impurities in anastrozole active pharmaceutical ingredient. J. Braz. Chem. Soc. 2008, 19:397-404.
5. Ramachandra Reddy Y., Nandan Srinivasan R., Vijay Bharathi D., Nagaraju B., Saidu S., Reddy L., Ravindranath V., Suryanarayana Rao LC and LC-MS/MS study of forced decomposition behavior of anastrozole and establishment of validated stability-indicating analytical method for impurities estimation in low dose anastrozole tablets. J. Pharm. Biomed. Anal. 2009, 50:397-404.
6. Mendes G.D., Hamamoto D., Iiha J., Pereira A.D.S., De Nucci G. Anastrozole quantification in human plasma by high-performance liquid chromatography coupled to photo spray tandem mass spectrometry applied to pharmacokinetic studies. J. Chromatogr. B 2007, 850:553-559.
7. Buzdar A.U., Robertson J.F.R., Eiermann W., Nabholtz J.M. An overview of the pharmacology and pharmacokinetics of the newer generation aromatase inhibitors anastrozole, letrozole, and exemestane. Am. Cancer Soc. 2006, 95:2002-2016.
8. Mary Bock J.H., Bara I., Ledonne N., Martz A., Dyroff M. Validated assay for the quantification of anastrozole in human plasma by capillary gas chromatography-63Ni electron capture detection. J. Chromatogr. B 1991, 700:131.
9. Dowsett M., Martin L.-A., Smith I., Johnston S. Mechanisms of resistance to aromatase inhibitors. J. Steroid Biochem. Mol. Biol. 2005, 95:157-162.
10. Mouridsen H.T., Robert N.J. The role of Aromatase inhibitors as adjuvant therapy for early breast cancer in postmenopausal women. Eur. J. Cancer 2005, 41:1678-1689.
11. Plourde P.V., Dyroff M., Dukes M. Breast cancer: molecular genetics pathogenesis and therapeutics: M. Anne, Bowcock. Breast Cancer Res. Treat. 1994, 30:103-111.
12. Buzdar A.U., Jonat W., Howell A., Plourde P.V. A potent and selective aromatase inhibitor for the treatment of advanced breast cancer. J. Steroid Biochem. Mol. Biol. 1997, 61:145-149.
13. Plourde P.V., Dyroff M., Dowsett M., Demers L., Yates R., Webster A. A new oral, once-a-day aromatase inhibitor. J. Steroid Biochem. Mol. Biol. 1995, 53:175-179.
14. Repetto L., Vannozzi O., Hazini A., Sestini A., Pietropaolo M., Rosso R. Anastrozole and quinapril can be safely co administered to elderly women with breast cancer and hypertension: a pharmacokinetic study. Ann. Oncol. 2003, 14:1587-1588.
15. International Conference on Harmonization Guideline on Validation of Analytical Procedures: Text and Methodology; Q2 (R1) 2005.